14159 capital (GP), LLC Insider Trading $ALTH ALLOS THERAPEUTICS INC
Get free email notifications about insider trading for 14159 capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of 14159 capital (GP), LLC. 14159 capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
14159 capital (GP), LLC in ALLOS THERAPEUTICS INC
Trading Symbol: ALTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of 14159 capital (GP), LLC: 10% Owner
Holdings: 190,917 shares
Latest Transaction: Feb 06 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of 14159 capital (GP), LLC in ALLOS THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.26 | 22 | 182 | 190,917 | 190.9 K to 190.9 K (-0.01 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 24,857 | 203,176 | 190,939 | 215.8 K to 190.9 K (-11.52 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.11 | 4,725 | 38,299 | 215,796 | 220.5 K to 215.8 K (-2.14 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.17 | 1,200 | 9,806 | 220,521 | 221.7 K to 220.5 K (-0.54 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.16 | 6,392 | 52,180 | 221,721 | 228.1 K to 221.7 K (-2.80 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.46 | 24,256 | 205,191 | 228,113 | 252.4 K to 228.1 K (-9.61 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.47 | 2,593 | 21,961 | 252,369 | 255 K to 252.4 K (-1.02 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 9.03 | 269 | 2,430 | 254,962 | 255.2 K to 255 K (-0.11 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 8.01 | 9,468 | 75,804 | 522,231 | 531.7 K to 522.2 K (-1.78 %) |
May 27 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.64 | 36,784 | 207,462 | 264,699 | 227.9 K to 264.7 K (+16.14 %) |
Feb 27 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 2,699 | 16,194 | 227,915 | 225.2 K to 227.9 K (+1.20 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.20 | 1,888 | 11,706 | 225,216 | 223.3 K to 225.2 K (+0.85 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.90 | 2,025 | 11,948 | 223,328 | 221.3 K to 223.3 K (+0.92 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.50 | 2,058 | 13,376 | 221,303 | 219.2 K to 221.3 K (+0.94 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.75 | 2,039 | 13,770 | 219,245 | 217.2 K to 219.2 K (+0.94 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.95 | 624 | 4,338 | 217,206 | 216.6 K to 217.2 K (+0.29 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.92 | 19 | 131 | 216,582 | 216.6 K to 216.6 K (+0.01 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.15 | 138 | 987 | 216,563 | 216.4 K to 216.6 K (+0.06 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.22 | 159 | 1,147 | 216,425 | 216.3 K to 216.4 K (+0.07 %) |
Jan 17 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.50 | 620 | 4,650 | 216,266 | 215.6 K to 216.3 K (+0.29 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.41 | 2,847 | 21,110 | 215,646 | 212.8 K to 215.6 K (+1.34 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.47 | 1,205 | 9,005 | 212,799 | 211.6 K to 212.8 K (+0.57 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.47 | 2,536 | 18,942 | 211,594 | 209.1 K to 211.6 K (+1.21 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.96 | 1,368 | 9,522 | 209,058 | 207.7 K to 209.1 K (+0.66 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 7.21 | 4,380 | 31,587 | 207,690 | 203.3 K to 207.7 K (+2.15 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.85 | 2,191 | 15,008 | 203,310 | 201.1 K to 203.3 K (+1.09 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.37 | 28 | 178 | 201,119 | 201.1 K to 201.1 K (+0.01 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.37 | 4 | 25 | 201,091 | 201.1 K to 201.1 K (0.00 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.55 | 2,063 | 11,452 | 201,087 | 203.2 K to 201.1 K (-1.02 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.85 | 4,107 | 24,016 | 203,150 | 207.3 K to 203.2 K (-1.98 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.64 | 17,408 | 98,148 | 207,257 | 224.7 K to 207.3 K (-7.75 %) |
Jun 21 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Sell | S | 5.76 | 3,750 | 21,586 | 224,665 | 228.4 K to 224.7 K (-1.64 %) |
Feb 01 2007 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 76,772 | 460,632 | 228,415 | 151.6 K to 228.4 K (+50.63 %) |
Nov 30 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.50 | 7,378 | 40,579 | 151,643 | 144.3 K to 151.6 K (+5.11 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.75 | 2,802 | 16,101 | 144,265 | 141.5 K to 144.3 K (+1.98 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.80 | 3,776 | 21,912 | 141,463 | 137.7 K to 141.5 K (+2.74 %) |
Nov 20 2006 | ALTH | ALLOS THERAPEUTICS ... | 14159 capital (GP), LLC | 10% Owner | Buy | P | 5.66 | 11,206 | 63,392 | 137,687 | 126.5 K to 137.7 K (+8.86 %) |
Page: 1